Global Anti-Asthmatic Drugs Market Research Report 2020

Global Anti-Asthmatic Drugs Market Research Report 2020

Feb 2020 QYResearch Pharmaceutical117 Pages Price :
$ 2900
This report focuses on Anti-Asthmatic Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-Asthmatic Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Abdi Ibrahim
Ception Therapeutics
Elan
Innoviva
Novartis
Sanofi
Mitsubishi Tanabe Pharma
Menarini
Dong-A Socio Holdings
Lonza
Sosei
Regeneron Pharmaceuticals
Theravance Biopharma
Lonza

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Long-term Control Medications
Quick-relief Medications (Rescue Medications)
Medications for Allergy-induced Asthma

Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy


Table of Contents

1 Anti-Asthmatic Drugs Market Overview
1.1 Product Overview and Scope of Anti-Asthmatic Drugs
1.2 Anti-Asthmatic Drugs Segment by Type
1.2.1 Global Anti-Asthmatic Drugs Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Long-term Control Medications
1.2.3 Quick-relief Medications (Rescue Medications)
1.2.4 Medications for Allergy-induced Asthma
1.3 Anti-Asthmatic Drugs Segment by Application
1.3.1 Anti-Asthmatic Drugs Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Anti-Asthmatic Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti-Asthmatic Drugs Revenue 2015-2026
1.4.2 Global Anti-Asthmatic Drugs Sales 2015-2026
1.4.3 Anti-Asthmatic Drugs Market Size by Region: 2020 Versus 2026

2 Global Anti-Asthmatic Drugs Market Competition by Manufacturers
2.1 Global Anti-Asthmatic Drugs Sales Market Share by Manufacturers (2015-2020)
2.2 Global Anti-Asthmatic Drugs Revenue Share by Manufacturers (2015-2020)
2.3 Global Anti-Asthmatic Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Anti-Asthmatic Drugs Manufacturing Sites, Area Served, Product Type
2.5 Anti-Asthmatic Drugs Market Competitive Situation and Trends
2.5.1 Anti-Asthmatic Drugs Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Anti-Asthmatic Drugs Players (Opinion Leaders)

3 Anti-Asthmatic Drugs Retrospective Market Scenario by Region
3.1 Global Anti-Asthmatic Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Anti-Asthmatic Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Anti-Asthmatic Drugs Market Facts & Figures by Country
3.3.1 North America Anti-Asthmatic Drugs Sales by Country
3.3.2 North America Anti-Asthmatic Drugs Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Anti-Asthmatic Drugs Market Facts & Figures by Country
3.4.1 Europe Anti-Asthmatic Drugs Sales by Country
3.4.2 Europe Anti-Asthmatic Drugs Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Anti-Asthmatic Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Anti-Asthmatic Drugs Sales by Region
3.5.2 Asia Pacific Anti-Asthmatic Drugs Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Anti-Asthmatic Drugs Market Facts & Figures by Country
3.6.1 Latin America Anti-Asthmatic Drugs Sales by Country
3.6.2 Latin America Anti-Asthmatic Drugs Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Anti-Asthmatic Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Anti-Asthmatic Drugs Sales by Country
3.7.2 Middle East and Africa Anti-Asthmatic Drugs Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Anti-Asthmatic Drugs Historic Market Analysis by Type
4.1 Global Anti-Asthmatic Drugs Sales Market Share by Type (2015-2020)
4.2 Global Anti-Asthmatic Drugs Revenue Market Share by Type (2015-2020)
4.3 Global Anti-Asthmatic Drugs Price Market Share by Type (2015-2020)
4.4 Global Anti-Asthmatic Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Anti-Asthmatic Drugs Historic Market Analysis by Application
5.1 Global Anti-Asthmatic Drugs Sales Market Share by Application (2015-2020)
5.2 Global Anti-Asthmatic Drugs Revenue Market Share by Application (2015-2020)
5.3 Global Anti-Asthmatic Drugs Price by Application (2015-2020)

6 Company Profiles and Key Figures in Anti-Asthmatic Drugs Business
6.1 Abdi Ibrahim
6.1.1 Corporation Information
6.1.2 Abdi Ibrahim Description, Business Overview and Total Revenue
6.1.3 Abdi Ibrahim Anti-Asthmatic Drugs Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Abdi Ibrahim Products Offered
6.1.5 Abdi Ibrahim Recent Development
6.2 Ception Therapeutics
6.2.1 Ception Therapeutics Anti-Asthmatic Drugs Production Sites and Area Served
6.2.2 Ception Therapeutics Description, Business Overview and Total Revenue
6.2.3 Ception Therapeutics Anti-Asthmatic Drugs Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Ception Therapeutics Products Offered
6.2.5 Ception Therapeutics Recent Development
6.3 Elan
6.3.1 Elan Anti-Asthmatic Drugs Production Sites and Area Served
6.3.2 Elan Description, Business Overview and Total Revenue
6.3.3 Elan Anti-Asthmatic Drugs Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Elan Products Offered
6.3.5 Elan Recent Development
6.4 Innoviva
6.4.1 Innoviva Anti-Asthmatic Drugs Production Sites and Area Served
6.4.2 Innoviva Description, Business Overview and Total Revenue
6.4.3 Innoviva Anti-Asthmatic Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Innoviva Products Offered
6.4.5 Innoviva Recent Development
6.5 Novartis
6.5.1 Novartis Anti-Asthmatic Drugs Production Sites and Area Served
6.5.2 Novartis Description, Business Overview and Total Revenue
6.5.3 Novartis Anti-Asthmatic Drugs Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Novartis Products Offered
6.5.5 Novartis Recent Development
6.6 Sanofi
6.6.1 Sanofi Anti-Asthmatic Drugs Production Sites and Area Served
6.6.2 Sanofi Description, Business Overview and Total Revenue
6.6.3 Sanofi Anti-Asthmatic Drugs Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Sanofi Products Offered
6.6.5 Sanofi Recent Development
6.7 Mitsubishi Tanabe Pharma
6.6.1 Mitsubishi Tanabe Pharma Anti-Asthmatic Drugs Production Sites and Area Served
6.6.2 Mitsubishi Tanabe Pharma Description, Business Overview and Total Revenue
6.6.3 Mitsubishi Tanabe Pharma Anti-Asthmatic Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Mitsubishi Tanabe Pharma Products Offered
6.7.5 Mitsubishi Tanabe Pharma Recent Development
6.8 Menarini
6.8.1 Menarini Anti-Asthmatic Drugs Production Sites and Area Served
6.8.2 Menarini Description, Business Overview and Total Revenue
6.8.3 Menarini Anti-Asthmatic Drugs Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Menarini Products Offered
6.8.5 Menarini Recent Development
6.9 Dong-A Socio Holdings
6.9.1 Dong-A Socio Holdings Anti-Asthmatic Drugs Production Sites and Area Served
6.9.2 Dong-A Socio Holdings Description, Business Overview and Total Revenue
6.9.3 Dong-A Socio Holdings Anti-Asthmatic Drugs Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Dong-A Socio Holdings Products Offered
6.9.5 Dong-A Socio Holdings Recent Development
6.10 Lonza
6.10.1 Lonza Anti-Asthmatic Drugs Production Sites and Area Served
6.10.2 Lonza Description, Business Overview and Total Revenue
6.10.3 Lonza Anti-Asthmatic Drugs Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Lonza Products Offered
6.10.5 Lonza Recent Development
6.11 Sosei
6.11.1 Sosei Anti-Asthmatic Drugs Production Sites and Area Served
6.11.2 Sosei Anti-Asthmatic Drugs Description, Business Overview and Total Revenue
6.11.3 Sosei Anti-Asthmatic Drugs Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Sosei Products Offered
6.11.5 Sosei Recent Development
6.12 Regeneron Pharmaceuticals
6.12.1 Regeneron Pharmaceuticals Anti-Asthmatic Drugs Production Sites and Area Served
6.12.2 Regeneron Pharmaceuticals Anti-Asthmatic Drugs Description, Business Overview and Total Revenue
6.12.3 Regeneron Pharmaceuticals Anti-Asthmatic Drugs Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Regeneron Pharmaceuticals Products Offered
6.12.5 Regeneron Pharmaceuticals Recent Development
6.13 Theravance Biopharma
6.13.1 Theravance Biopharma Anti-Asthmatic Drugs Production Sites and Area Served
6.13.2 Theravance Biopharma Anti-Asthmatic Drugs Description, Business Overview and Total Revenue
6.13.3 Theravance Biopharma Anti-Asthmatic Drugs Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Theravance Biopharma Products Offered
6.13.5 Theravance Biopharma Recent Development
6.14 Lonza
6.14.1 Lonza Anti-Asthmatic Drugs Production Sites and Area Served
6.14.2 Lonza Anti-Asthmatic Drugs Description, Business Overview and Total Revenue
6.14.3 Lonza Anti-Asthmatic Drugs Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Lonza Products Offered
6.14.5 Lonza Recent Development

7 Anti-Asthmatic Drugs Manufacturing Cost Analysis
7.1 Anti-Asthmatic Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Anti-Asthmatic Drugs
7.4 Anti-Asthmatic Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Anti-Asthmatic Drugs Distributors List
8.3 Anti-Asthmatic Drugs Customers

9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 Global Market Forecast
10.1 Global Anti-Asthmatic Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Anti-Asthmatic Drugs by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Anti-Asthmatic Drugs by Type (2021-2026)
10.2 Anti-Asthmatic Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Anti-Asthmatic Drugs by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Anti-Asthmatic Drugs by Application (2021-2026)
10.3 Anti-Asthmatic Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Anti-Asthmatic Drugs by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Anti-Asthmatic Drugs by Region (2021-2026)
10.4 North America Anti-Asthmatic Drugs Estimates and Projections (2021-2026)
10.5 Europe Anti-Asthmatic Drugs Estimates and Projections (2021-2026)
10.6 Asia Pacific Anti-Asthmatic Drugs Estimates and Projections (2021-2026)
10.7 Latin America Anti-Asthmatic Drugs Estimates and Projections (2021-2026)
10.8 Middle East and Africa Anti-Asthmatic Drugs Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Table

List of Tables
Table 1. Global Anti-Asthmatic Drugs Sales (K Doses) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Anti-Asthmatic Drugs Sales (K Doses) Comparison by Application: 2020 VS 2026
Table 3. Global Anti-Asthmatic Drugs Market Size by Type (K Doses) (US$ Million) (2020 VS 2026)
Table 4. Global Key Anti-Asthmatic Drugs Manufacturers Covered in This Study
Table 5. Global Anti-Asthmatic Drugs Sales (K Doses) by Manufacturers (2015-2020)
Table 6. Global Anti-Asthmatic Drugs Sales Share by Manufacturers (2015-2020)
Table 7. Global Anti-Asthmatic Drugs Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Anti-Asthmatic Drugs Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Anti-Asthmatic Drugs Average Price (USD/Dose) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Anti-Asthmatic Drugs Sales Sites and Area Served
Table 11. Manufacturers Anti-Asthmatic Drugs Product Types
Table 12. Global Anti-Asthmatic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Anti-Asthmatic Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Asthmatic Drugs as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Anti-Asthmatic Drugs Players
Table 16. Global Anti-Asthmatic Drugs Sales (K Doses) by Region (2015-2020)
Table 17. Global Anti-Asthmatic Drugs Sales Market Share by Region (2015-2020)
Table 18. Global Anti-Asthmatic Drugs Revenue (Million US$) by Region (2015-2020)
Table 19. Global Anti-Asthmatic Drugs Revenue Market Share by Region (2015-2020)
Table 20. North America Anti-Asthmatic Drugs Sales by Country (2015-2020) (K Doses)
Table 21. North America Anti-Asthmatic Drugs Sales Market Share by Country (2015-2020)
Table 22. North America Anti-Asthmatic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Anti-Asthmatic Drugs Revenue Market Share by Country (2015-2020)
Table 24. Europe Anti-Asthmatic Drugs Sales by Country (2015-2020) (K Doses)
Table 25. Europe Anti-Asthmatic Drugs Sales Market Share by Country (2015-2020)
Table 26. Europe Anti-Asthmatic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Anti-Asthmatic Drugs Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Anti-Asthmatic Drugs Sales by Region (2015-2020) (K Doses)
Table 29. Asia Pacific Anti-Asthmatic Drugs Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Anti-Asthmatic Drugs Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Anti-Asthmatic Drugs Revenue Market Share by Region (2015-2020)
Table 32. Latin America Anti-Asthmatic Drugs Sales by Country (2015-2020) (K Doses)
Table 33. Latin America Anti-Asthmatic Drugs Sales Market Share by Country (2015-2020)
Table 34. Latin America Anti-Asthmatic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Anti-Asthmatic Drugs Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Anti-Asthmatic Drugs Sales by Country (2015-2020) (K Doses)
Table 37. Middle East and Africa Anti-Asthmatic Drugs Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Anti-Asthmatic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Anti-Asthmatic Drugs Revenue Market Share by Country (2015-2020)
Table 40. Global Anti-Asthmatic Drugs Sales (K Doses) by Type (2015-2020)
Table 41. Global Anti-Asthmatic Drugs Sales Share by Type (2015-2020)
Table 42. Global Anti-Asthmatic Drugs Revenue (Million US$) by Type (2015-2020)
Table 43. Global Anti-Asthmatic Drugs Revenue Share by Type (2015-2020)
Table 44. Global Anti-Asthmatic Drugs Price (USD/Dose) by Type (2015-2020)
Table 45. Global Anti-Asthmatic Drugs Sales (K Doses) by Application (2015-2020)
Table 46. Global Anti-Asthmatic Drugs Sales Market Share by Application (2015-2020)
Table 47. Global Anti-Asthmatic Drugs Sales Growth Rate by Application (2015-2020)
Table 48. Abdi Ibrahim Anti-Asthmatic Drugs Corporation Information
Table 49. Abdi Ibrahim Description and Business Overview
Table 50. Abdi Ibrahim Anti-Asthmatic Drugs Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 51. Abdi Ibrahim Main Product
Table 52. Abdi Ibrahim Recent Development
Table 53. Ception Therapeutics Anti-Asthmatic Drugs Corporation Information
Table 54. Ception Therapeutics Corporation Information
Table 55. Ception Therapeutics Anti-Asthmatic Drugs Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 56. Ception Therapeutics Main Product
Table 57. Ception Therapeutics Recent Development
Table 58. Elan Anti-Asthmatic Drugs Corporation Information
Table 59. Elan Corporation Information
Table 60. Elan Anti-Asthmatic Drugs Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 61. Elan Main Product
Table 62. Elan Recent Development
Table 63. Innoviva Anti-Asthmatic Drugs Corporation Information
Table 64. Innoviva Corporation Information
Table 65. Innoviva Anti-Asthmatic Drugs Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 66. Innoviva Main Product
Table 67. Innoviva Recent Development
Table 68. Novartis Anti-Asthmatic Drugs Corporation Information
Table 69. Novartis Corporation Information
Table 70. Novartis Anti-Asthmatic Drugs Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 71. Novartis Main Product
Table 72. Novartis Recent Development
Table 73. Sanofi Anti-Asthmatic Drugs Corporation Information
Table 74. Sanofi Corporation Information
Table 75. Sanofi Anti-Asthmatic Drugs Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 76. Sanofi Main Product
Table 77. Sanofi Recent Development
Table 78. Mitsubishi Tanabe Pharma Anti-Asthmatic Drugs Corporation Information
Table 79. Mitsubishi Tanabe Pharma Corporation Information
Table 80. Mitsubishi Tanabe Pharma Anti-Asthmatic Drugs Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 81. Mitsubishi Tanabe Pharma Main Product
Table 82. Mitsubishi Tanabe Pharma Recent Development
Table 83. Menarini Anti-Asthmatic Drugs Corporation Information
Table 84. Menarini Corporation Information
Table 85. Menarini Anti-Asthmatic Drugs Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 86. Menarini Main Product
Table 87. Menarini Recent Development
Table 88. Dong-A Socio Holdings Anti-Asthmatic Drugs Corporation Information
Table 89. Dong-A Socio Holdings Corporation Information
Table 90. Dong-A Socio Holdings Anti-Asthmatic Drugs Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 91. Dong-A Socio Holdings Main Product
Table 92. Dong-A Socio Holdings Recent Development
Table 93. Lonza Anti-Asthmatic Drugs Corporation Information
Table 94. Lonza Corporation Information
Table 95. Lonza Anti-Asthmatic Drugs Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 96. Lonza Main Product
Table 97. Lonza Recent Development
Table 98. Sosei Anti-Asthmatic Drugs Corporation Information
Table 99. Sosei Corporation Information
Table 100. Sosei Anti-Asthmatic Drugs Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 101. Sosei Main Product
Table 102. Sosei Recent Development
Table 103. Regeneron Pharmaceuticals Anti-Asthmatic Drugs Corporation Information
Table 104. Regeneron Pharmaceuticals Corporation Information
Table 105. Regeneron Pharmaceuticals Anti-Asthmatic Drugs Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 106. Regeneron Pharmaceuticals Main Product
Table 107. Regeneron Pharmaceuticals Recent Development
Table 108. Theravance Biopharma Anti-Asthmatic Drugs Corporation Information
Table 109. Theravance Biopharma Corporation Information
Table 110. Theravance Biopharma Anti-Asthmatic Drugs Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 111. Theravance Biopharma Main Product
Table 112. Theravance Biopharma Recent Development
Table 113. Lonza Anti-Asthmatic Drugs Corporation Information
Table 114. Lonza Corporation Information
Table 115. Lonza Anti-Asthmatic Drugs Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 116. Lonza Main Product
Table 117. Lonza Recent Development
Table 118. Sales Base and Market Concentration Rate of Raw Material
Table 119. Key Suppliers of Raw Materials
Table 120. Anti-Asthmatic Drugs Distributors List
Table 121. Anti-Asthmatic Drugs Customers List
Table 122. Market Key Trends
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Global Anti-Asthmatic Drugs Sales (K Doses) Forecast by Type (2021-2026)
Table 126. Global Anti-Asthmatic Drugs Sales Market Share Forecast by Type (2021-2026)
Table 127. Global Anti-Asthmatic Drugs Revenue (Million US$) Forecast by Type (2021-2026)
Table 128. Global Anti-Asthmatic Drugs Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 129. Global Anti-Asthmatic Drugs Sales (K Doses) Forecast by Application (2021-2026)
Table 130. Global Anti-Asthmatic Drugs Revenue (Million US$) Forecast by Application (2021-2026)
Table 131. Global Anti-Asthmatic Drugs Sales (K Doses) Forecast by Region (2021-2026)
Table 132. Global Anti-Asthmatic Drugs Sales Market Share Forecast by Region (2021-2026)
Table 133. Global Anti-Asthmatic Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 134. Global Anti-Asthmatic Drugs Revenue Market Share Forecast by Region (2021-2026)
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Anti-Asthmatic Drugs
Figure 2. Global Anti-Asthmatic Drugs Sales Market Share by Type: 2020 VS 2026
Figure 3. Long-term Control Medications Product Picture
Figure 4. Quick-relief Medications (Rescue Medications) Product Picture
Figure 5. Medications for Allergy-induced Asthma Product Picture
Figure 6. Global Anti-Asthmatic Drugs Consumption Market Share by Application: 2020 VS 2026
Figure 7. Hospital Pharmacy
Figure 8. Retail Pharmacy
Figure 9. Online Pharmacy
Figure 10. Global Anti-Asthmatic Drugs Market Size 2015-2026 (US$ Million)
Figure 11. Global Anti-Asthmatic Drugs Sales Capacity (K Doses) (2015-2026)
Figure 12. Global Anti-Asthmatic Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Anti-Asthmatic Drugs Sales Share by Manufacturers in 2020
Figure 14. Global Anti-Asthmatic Drugs Revenue Share by Manufacturers in 2019
Figure 15. The Global 5 and 10 Largest Players: Market Share by Anti-Asthmatic Drugs Revenue in 2019
Figure 16. Anti-Asthmatic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Anti-Asthmatic Drugs Sales Market Share by Region (2015-2020)
Figure 18. Global Anti-Asthmatic Drugs Sales Market Share by Region in 2019
Figure 19. Global Anti-Asthmatic Drugs Revenue Market Share by Region (2015-2020)
Figure 20. Global Anti-Asthmatic Drugs Revenue Market Share by Region in 2019
Figure 21. North America Anti-Asthmatic Drugs Sales Market Share by Country in 2019
Figure 22. North America Anti-Asthmatic Drugs Revenue Market Share by Country in 2019
Figure 23. U.S. Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 24. U.S. Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Canada Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 26. Canada Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Europe Anti-Asthmatic Drugs Sales Market Share by Country in 2019
Figure 28. Europe Anti-Asthmatic Drugs Revenue Market Share by Country in 2019
Figure 29. Germany Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 30. Germany Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. France Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 32. France Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. U.K. Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 34. U.K. Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Italy Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 36. Italy Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Russia Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 38. Russia Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Asia Pacific Anti-Asthmatic Drugs Sales Market Share by Region in 2019
Figure 40. Asia Pacific Anti-Asthmatic Drugs Revenue Market Share by Region in 2019
Figure 41. China Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 42. China Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Japan Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 44. Japan Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. South Korea Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 46. South Korea Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. India Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 48. India Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Australia Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 50. Australia Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Taiwan Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 52. Taiwan Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Indonesia Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 54. Indonesia Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Thailand Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 56. Thailand Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Malaysia Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 58. Malaysia Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Philippines Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 60. Philippines Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Vietnam Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 62. Vietnam Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Latin America Anti-Asthmatic Drugs Sales Market Share by Country in 2019
Figure 64. Latin America Anti-Asthmatic Drugs Revenue Market Share by Country in 2019
Figure 65. Mexico Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 66. Mexico Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Brazil Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 68. Brazil Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Argentina Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 70. Argentina Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Middle East and Africa Anti-Asthmatic Drugs Sales Market Share by Country in 2019
Figure 72. Middle East and Africa Anti-Asthmatic Drugs Revenue Market Share by Country in 2019
Figure 73. Turkey Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 74. Turkey Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Saudi Arabia Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 76. Saudi Arabia Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. U.A.E Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 78. U.A.E Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Sales Market Share of Anti-Asthmatic Drugs by Type (2015-2020)
Figure 80. Sales Market Share of Anti-Asthmatic Drugs by Type in 2019
Figure 81. Revenue Share of Anti-Asthmatic Drugs by Type (2015-2020)
Figure 82. Revenue Market Share of Anti-Asthmatic Drugs by Type in 2019
Figure 83. Global Anti-Asthmatic Drugs Sales Growth by Type (2015-2020) (K Doses)
Figure 84. Global Anti-Asthmatic Drugs Sales Market Share by Application (2015-2020)
Figure 85. Global Anti-Asthmatic Drugs Sales Market Share by Application in 2019
Figure 86. Global Revenue Share of Anti-Asthmatic Drugs by Application (2015-2020)
Figure 87. Global Revenue Share of Anti-Asthmatic Drugs by Application in 2020
Figure 88. Abdi Ibrahim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Ception Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Elan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Innoviva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Mitsubishi Tanabe Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Menarini Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Dong-A Socio Holdings Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Lonza Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Sosei Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Regeneron Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Theravance Biopharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Lonza Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Price Trend of Key Raw Materials
Figure 103. Manufacturing Cost Structure of Anti-Asthmatic Drugs
Figure 104. Manufacturing Process Analysis of Anti-Asthmatic Drugs
Figure 105. Anti-Asthmatic Drugs Industrial Chain Analysis
Figure 106. Channels of Distribution
Figure 107. Distributors Profiles
Figure 108. Porter's Five Forces Analysis
Figure 109. North America Anti-Asthmatic Drugs Sales (K Doses) and Growth Rate Forecast (2021-2026)
Figure 110. North America Anti-Asthmatic Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Europe Anti-Asthmatic Drugs Sales (K Doses) and Growth Rate Forecast (2021-2026)
Figure 112. Europe Anti-Asthmatic Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Latin America Anti-Asthmatic Drugs Sales (K Doses) and Growth Rate Forecast (2021-2026)
Figure 114. Latin America Anti-Asthmatic Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Middle East and Africa Anti-Asthmatic Drugs Sales (K Doses) and Growth Rate Forecast (2021-2026)
Figure 116. Middle East and Africa Anti-Asthmatic Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 117. Asia Pacific Anti-Asthmatic Drugs Sales (K Doses) and Growth Rate Forecast (2021-2026)
Figure 118. Asia Pacific Anti-Asthmatic Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Country :
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 2900
$ 4350

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top